Phase II Randomized Placebo-Controlled Trial of Cisplatin with or without ABT-888 (Veliparib) in Metastatic Triple-Negative Breast Cancer and/or BRCA Mutation-Associated Breast Cancer

Study Number:S1416
IRB Number:1053708
Trial Type:Oncology - Breast
Trial Status:Open to Accrual
Date Posted:05/15/2017
Principal Investigator:Madhu Chaudhry, MD
Contact Name:Melissa Loomis
Fax:(443) 849-3777

For more details on this study, please refer to the website at the link below:

IMPORTANT Visitor Policy Changes

Recent Stories
In the Media